拔管后无创通气失败的预测因素:系统评价与Meta分析
该系统评价与Meta分析检索Embase Classic+、MEDLINE和Cochrane系统评价数据库(截至2022年2月28日),纳入25项研究(n=2327),旨在识别拔管后无创通气失败需重新插管的预测因素。结果显示,疾病严重程度较高(OR 3.56;95%CI 1.96-6.45;高确定性)和肺炎诊断(OR 6.16;95%CI 2.59-14.66;中等确定性)与失败风险增加相关;呼吸频率较高(MD 1.54;95%CI 0.61-2.47)、心率较高(MD 4.46;95%CI 1.67-7.25)、无创通气启动后1小时PaO2:FIO2较低(MD -30.78;95%CI -50.02至-11.54)和无创通气启动前快速浅呼吸指数较高(MD 15.21;95%CI 12.04-18.38)也与失败风险增加相关(中等确定性)。体重指数升高可能是唯一的保护因素(OR 0.21;95%CI 0.09-0.52;中等确定性)。作者认为需要精心设计的前瞻性研究来确认这些因素的预后重要性。
要点
- 疾病严重程度较高与拔管后无创通气失败风险增加相关(OR 3.56;95%CI 1.96-6.45;高确定性)。
- 肺炎诊断与拔管后无创通气失败风险增加相关(OR 6.16;95%CI 2.59-14.66;中等确定性)。
- 无创通气启动后1小时PaO2:FIO2较低(MD -30.78;95%CI -50.02至-11.54)和启动前快速浅呼吸指数较高(MD 15.21;95%CI 12.04-18.38)与失败风险增加相关(中等确定性)。
- 呼吸频率较高(MD 1.54;95%CI 0.61-2.47)和心率较高(MD 4.46;95%CI 1.67-7.25)与失败风险增加相关(中等确定性)。
- 体重指数升高可能是唯一的保护因素(OR 0.21;95%CI 0.09-0.52;中等确定性)。
适用人群与场景
- 拔管后接受无创通气的成人患者(纳入的25项研究,n=2327)。
研究设计与关键结果
- 系统评价与Meta分析纳入25项研究(n=2327),汇总估计拔管后无创通气失败需重新插管的预测因素。
- 疾病严重程度较高与拔管后无创通气失败风险增加相关(OR 3.56;95%CI 1.96-6.45;高确定性)。
- 肺炎诊断与拔管后无创通气失败风险增加相关(OR 6.16;95%CI 2.59-14.66;中等确定性)。
- 呼吸频率较高与拔管后无创通气失败风险增加相关(MD 1.54;95%CI 0.61-2.47;中等确定性)。
- 心率较高与拔管后无创通气失败风险增加相关(MD 4.46;95%CI 1.67-7.25;中等确定性)。
- 无创通气启动后1小时PaO2:FIO2较低与拔管后无创通气失败风险增加相关(MD -30.78;95%CI -50.02至-11.54;中等确定性)。
- 无创通气启动前快速浅呼吸指数较高与拔管后无创通气失败风险增加相关(MD 15.21;95%CI 12.04-18.38;中等确定性)。
- 体重指数升高可能是拔管后无创通气失败的唯一保护因素(OR 0.21;95%CI 0.09-0.52;中等确定性)。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析;采用随机效应模型合并二分类和连续数据,分别用OR和MD汇总效应估计。
- 使用预后研究质量工具评估偏倚风险,使用推荐分级的评估、制定与评价(GRADE)评估确定性。
- 局限性:作者指出需要精心设计的前瞻性研究来确认这些因素的预后重要性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To identify factors associated with failure of noninvasive ventilation (NIV) in the post-extubation period.
DATA SOURCES: We searched Embase Classic +, MEDLINE, and the Cochrane Database of Systematic Reviews from inception to February 28, 2022.
STUDY SELECTION: We included English language studies that provided predictors of post-extubation NIV failure necessitating reintubation.
DATA EXTRACTION: Two authors conducted data abstraction and risk-of-bias assessments independently. We used a random-effects model to pool binary and continuous data and summarized estimates of effect using odds ratios (ORs) mean difference (MD), respectively. We used the Quality in Prognosis Studies tool to assess risk of bias and the Grading of Recommendations, Assessment, Development and Evaluations to assess certainty.
DATA SYNTHESIS: We included 25 studies ( n = 2,327). Illness-related factors associated with increased odds of post-extubation NIV failure were higher critical illness severity (OR, 3.56; 95% CI, 1.96-6.45; high certainty) and a diagnosis of pneumonia (OR, 6.16; 95% CI, 2.59-14.66; moderate certainty). Clinical and biochemical factors associated with moderate certainty of increased risk of NIV failure post-extubation include higher respiratory rate (MD, 1.54; 95% CI, 0.61-2.47), higher heart rate (MD, 4.46; 95% CI, 1.67-7.25), lower Pa o2 :F io2 (MD, -30.78; 95% CI, -50.02 to -11.54) 1-hour after NIV initiation, and higher rapid shallow breathing index (MD, 15.21; 95% CI, 12.04-18.38) prior to NIV start. Elevated body mass index was the only patient-related factor that may be associated with a protective effect (OR, 0.21; 95% CI, 0.09-0.52; moderate certainty) on post-extubation NIV failure.
CONCLUSIONS: We identified several prognostic factors before and 1 hour after NIV initiation associated with increased risk of NIV failure in the post-extubation period. Well-designed prospective studies are required to confirm the prognostic importance of these factors to help further guide clinical decision-making.
参考来源
- Hryciw BN, Hryciw N, Tran A, et al. Predictors of Noninvasive Ventilation Failure in the Post-Extubation Period: A Systematic Review and Meta-Analysis. Crit Care Med. 2023. PMID: 36995099. doi:10.1097/CCM.0000000000005865
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。